Analysts Set IMAX Co. (NYSE:IMAX) Price Target at $23.67
Shares of IMAX Co. (NYSE:IMAX – Get Free Report) have received an average recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, seven have given a buy recommendation and one has […]
Analysts Set Forward Air Co. (NASDAQ:FWRD) Target Price at $51.00
Shares of Forward Air Co. (NASDAQ:FWRD – Get Free Report) have been given an average recommendation of “Hold” by the five research firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year […]
Evercore ISI Boosts Boston Scientific (NYSE:BSX) Price Target to $90.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Evercore ISI from $82.00 to $90.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. Several other equities research analysts have also recently weighed in on BSX. Raymond James increased […]
Evercore ISI Boosts Boston Scientific (NYSE:BSX) Price Target to $90.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Evercore ISI from $82.00 to $90.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. Several other equities research analysts have also recently weighed in on BSX. Raymond James increased […]
Insmed Incorporated (NASDAQ:INSM) Receives $81.40 Consensus Target Price from Brokerages
Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been given an average rating of “Buy” by the sixteen brokerages that are presently covering the company, MarketBeat reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued a report on the stock in the […]
Prime Medicine, Inc. (NYSE:PRME) Receives $14.11 Consensus Target Price from Analysts
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month […]
last updated on 6 Oct 10:27